GlassScriptPhysician profile
Rachel Sensenig
NPI 1922244342
$814.91
in general payments reported to CMS, 2019-2025
7 companies · $443 in 2025
The $443 reported for 2025 was more than what a typical Trauma Surgery provider received nationally (typical 2025 total: $294).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $18.22 · 2020: $78.69 · 2021: $161 · 2022: $12.80 · 2023: $102 · 2025: $443.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Long Term Medical Supply Or Device Loan: $343 · Food and Beverage: $201.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Long Term Medical Supply Or Device Loan | $343.02 |
| Food and Beverage | $201.44 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Integra Lifesciences Corporation | $442.84 | 2025 | Integra, Micromatrix, Integra Dermal Regeneration Template |
| Baxter Healthcare | $125.46 | 2019-2021 | |
| Ethicon US, LLC | $113.08 | 2021 | |
| Davol INC. | $58.90 | 2023 | Arista Ah Flexitip |
| Intuitive Surgical, INC. | $42.72 | 2023 | |
| Smith+Nephew, INC. | $19.11 | 2020 | |
| Astrazeneca Pharmaceuticals LP | $12.80 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Rachel Sensenig listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.